| SELEX | Systematic Evolution of Ligands by Exponential Enrichment |
| E-ABs | Electrochemical aptasensors |
| FRET | Förster Resonance Energy Transfer |
| CF | Cerebrospinal fluid |
| FDA | Food and Drug Administration |
| ISF | Interstitial fluid |
| CTCs | Circulating tumor cells |
| PCR | Polymerase chain reaction |
| MDs | Molecular dynamics |
| CEA | Carcinoembryonic antigen |
| PSA | Prostate-specific antigen |
| LDL | Low-density lipoprotein |
| rPfLDH | Plasmodium falciparum lactate dehydrogenase |
| PD-L1 | Programmed death ligand-1 |
| EVs | Extracellular vesicles |
| CRP | C-reactive protein |
| cTn-I | Cardiac troponin I |
| MCH | Mercaptohexanol |
| BBB | Blood–brain barrier |
| POC | Point-of-care |
| TDM | Therapeutic drug monitoring |
| FET | Field-effect transistor |
| PKU | Phenylketonuria |
| ATP | Adenosine triphosphate |